|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-10-26
|
|
pubmed:abstractText |
Evaluation of L-asparaginase therapy in the NOPHO-92 ALL-protocol (treatment protocol of acute lymphoblastic leukaemia of the Nordic Society of Paediatric Haematology and Oncology, initiated in 1992) after intravenous and intramuscular administration of Erwinia asparaginase during induction and re-induction therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11678787-Adolescent,
pubmed-meshheading:11678787-Asparaginase,
pubmed-meshheading:11678787-Asparagine,
pubmed-meshheading:11678787-Child,
pubmed-meshheading:11678787-Child, Preschool,
pubmed-meshheading:11678787-Chromatography, High Pressure Liquid,
pubmed-meshheading:11678787-Drug Administration Schedule,
pubmed-meshheading:11678787-Humans,
pubmed-meshheading:11678787-Infant,
pubmed-meshheading:11678787-Injections, Intramuscular,
pubmed-meshheading:11678787-Injections, Intravenous,
pubmed-meshheading:11678787-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11678787-Scandinavia
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.
|
|
pubmed:affiliation |
Centre for Clinical Pharmacology, University of Aarhus, Aarhus, Denmark. bka@farm.au.dk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
